Amarin Corporation plc Stock Deutsche Boerse AG
Stocks
EH3
US0231114044
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:01:55 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 10.40 EUR | 0.00% |
|
-4.59% | -12.61% |
| Market Cap | 254M 227M 211M 192M 363M 24.59B 364M 2.54B 996M 12.54B 954M 933M 40.24B | P/E 2026 * |
-172x | P/E 2027 * | -201x |
|---|---|---|---|---|---|
| Enterprise Value | 91.83M 82.01M 76.29M 69.4M 131M 8.89B 132M 918M 360M 4.53B 345M 337M 14.54B | EV / Sales 2026 * |
0.52x | EV / Sales 2027 * | 0.45x |
| Free-Float |
86.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMRN | Delayed | |
CBOE
| AMRN | Real-time | |
|
Deutsche Boerse AG
| EH3 | Delayed | |
|
Tradegate
| EH3 | Real-time | |
|
Börse Stuttgart
| EH3 | Delayed | |
|
Boerse Muenchen
| EH3 | Real-time |
Last Transcript: Amarin Corporation plc
| 1 week | -4.59% | ||
| Current month | -7.96% | ||
| 1 month | -12.61% | ||
| 3 months | -19.38% | ||
| 6 months | -14.75% | ||
| Current year | -12.61% |
| 1 week | 10.4 |  | 10.8 |
| 1 month | 10.4 | | 12 |
| Current year | 10.4 | | 14.1 |
| 1 year | 10.4 | | 17.2 |
| 3 years | 5.92 | | 25.2 |
| 5 years | 5.92 | | 88.8 |
| 10 years | 5.92 | | 540 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aaron Berg
CEO | Chief Executive Officer | 63 | 2024-06-03 |
Peter Fishman
DFI | Director of Finance/CFO | 42 | 2024-10-22 |
| Compliance Officer | 56 | 2023-11-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Berg
BRD | Director/Board Member | 63 | 2024-06-03 |
| Director/Board Member | 43 | 2023-02-27 | |
Keith Horn
BRD | Director/Board Member | 67 | 2023-02-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.59% | - | - | 254M | |
| -2.59% | -5.70% | +50.69% | +86.86% | 70.61B | |
| +3.23% | -10.67% | +6.27% | +53.70% | 51.01B | |
| +1.56% | +1.17% | +8.49% | +31.81% | 48.1B | |
| +0.39% | +0.65% | +31.14% | +28.97% | 42.78B | |
| +0.87% | -8.17% | +293.37% | +642.41% | 40.67B | |
| +1.24% | -1.01% | +10.74% | +100.64% | 40.3B | |
| -2.13% | -1.64% | +8.63% | +46.88% | 30.59B | |
| -0.46% | -1.28% | +42.23% | +20.34% | 28.16B | |
| +5.32% | +0.06% | -5.00% | -12.78% | 24.36B | |
| Average | +0.74% | -2.66% | +49.62% | +110.98% | 41.84B | |
| Weighted average by Cap. | +0.56% | -2.94% | +51.35% | +115.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 177M 158M 147M 134M 253M 17.17B 254M 1.77B 695M 8.76B 666M 652M 28.1B | 177M 158M 147M 134M 252M 17.11B 253M 1.77B 693M 8.73B 664M 650M 28B |
| Net income | -26.62M -23.78M -22.12M -20.12M -37.99M -2.58B -38.15M -266M -104M -1.31B -99.98M -97.79M -4.22B | -18.32M -16.36M -15.22M -13.84M -26.14M -1.77B -26.25M -183M -71.77M -904M -68.79M -67.29M -2.9B |
| Net Debt | -162M -145M -135M -123M -232M -15.71B -233M -1.62B -636M -8.01B -609M -596M -25.7B | -175M -156M -145M -132M -250M -16.93B -251M -1.75B -685M -8.63B -657M -642M -27.69B |
| Date | Price | Change |
|---|---|---|
| 26-10-09 | €10.40 | 0.00% |
| 26-10-08 | €10.40 | -0.95% |
| 26-10-07 | €10.50 | 0.00% |
| 26-10-06 | €10.50 | -1.87% |
| 26-10-05 | €10.70 | -1.83% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRN Stock
- EH3 Stock
Select your edition
All financial news and data tailored to specific country editions
